NOD2 and inflammatory bowel disease: Changes in NOD2 and ATG16L1, as well as other genes involved in the intestinal epithelial barrier, microbial sensing, and antimicrobial activity in IBD, demonstrate the impact of genetics on the intestinal microbiota.